Empowerment program for women with cervical cancer and HIV
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests a program to help women with cervical cancer and HIV feel more empowered and less judged by stigma. It takes place at the Cancer Disease Hospital in Zambia and offers support in your preferred language.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman diagnosed with both cervical cancer (any stage) and HIV.
- You are currently receiving cancer treatment at the Cancer Disease Hospital in Lusaka, Zambia.
- You are 18 years old or older.
- You can speak English, Bemba, Nyanja, Tonga, or Lozi.
- You do not have a major mental health condition like schizophrenia or bipolar disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial helps young people aged 18 to 24 living with HIV in three districts of Zambia. It aims to reduce stigma and build job skills to improve their lives.
This study tests a stigma-reducing support program to help women living with HIV and serious mental illness stay adherent to HIV treatment. It focuses on sustaining viral suppression by addressing stigma that can make care harder, and it involves family and community leaders as part of the approach.
This study tests a program to help people living with HIV and a new cancer diagnosis stay engaged in their treatment. It is based at Parirenyatwa Hospital in Zimbabwe.
This study is testing a program to reduce stigma and help women who use drugs stay engaged in HIV care. It aims to see if the program improves their health and well-being.
This study tests a program to reduce stigma for people living with HIV who also have symptoms of depression. It aims to improve mental health and HIV outcomes.
This study tests a mobile team approach to screen for cervical cancer using HPV testing in women living with HIV. It aims to make screening easier to access and more effective.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.